Fortis Healthcare Ltd. (FORTIS) fundamentals
Fortis Healthcare Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as FORTIS (ISIN INE061F01013). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Fortis Healthcare Ltd. does
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 28 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, the United Arab Emirates, Nepal, and Sri Lanka.
Valuation and market data
| Last close | ₹887.80 |
|---|---|
| Market capitalisation | ₹68,463 crore |
| Enterprise value | ₹71,817 crore |
| P/E (TTM) | 64.33 |
| Price to book | 6.73 |
| Price to sales (TTM) | 4.20 |
| Book value per share | ₹131.86 |
| Dividend yield | 11.26% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed May 09 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹1,958 crore | ₹269 crore | ₹230 crore | 3.05 |
| Mar 2025 | ₹1,644 crore | ₹114 crore | ₹64 crore | 0.84 |
| Mar 2024 | ₹1,324 crore | ₹247 crore | ₹199 crore | 2.64 |
| Mar 2023 | ₹1,203 crore | ₹109 crore | ₹96 crore | 1.27 |
| Mar 2022 | ₹997 crore | ₹-9 crore | ₹-13 crore | -0.18 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 31.2% |
|---|---|
| Foreign institutions (FII) | 25.2% |
| Mutual funds | 25.8% |
| Other domestic institutions | 6.4% |
| Retail and others | 11.4% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.